Rural America regularly presents some of the greatest challenges to quality myeloma care and cancer care in general. Though perhaps extreme, one example quickly came to mind for Daniel Nikcevich, MD, ...

Incidence of venous thromboembolism remains 'substantial' despite expert guidelines and newer risk prediction scores ...

Common manifestations and complications of multiple myeloma (MM) can include bone complications, hypercalcemia, renal insufficiency, infection, skeletal lesions and anemia. Other less common ...

The FDA has removed Risk Evaluation and Mitigation Strategies (REMS) for approved chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, aiming to ease provider burden and ...

Iberdomide and mezigdomide are currently being evaluated for the treatment of patients with multiple myeloma in a number of ...

Significant unmet need for patients requires new and novel treatments1 DREAMM-7 showed a 51% reduction in the risk of death and tripled median progression-free survival in 3L+ indicated population ...